Original ArticleCombining ECMO with IABP for the Treatment of Critically Ill Adult Heart Failure Patients
Introduction
The IABP is a device which increases aortic root pressure during diastole by enhancing blood flow into the coronary arteries, thus increasing blood supply to the cardiac muscle; meanwhile, it decreases the pressure in the aorta during systole, reducing left ventricular afterload and thus reducing cardiac muscle oxygen consumption. These effects allow the weakened heart to recover its function. IABP can improve blood flow to internal organs to a certain extent, while increasing cardiac output by 10–20% [1], thus providing indispensable assistance in meeting the body's metabolic needs. IABP is currently the most commonly used mechanical circulatory support device in the treatment of acute heart failure; when administered in a timely manner, it can play a critical role in the rescue of patients with acute ischaemic myocardial infarctions [2], [3]. Despite this, IABP cannot replace the physiological pumping of the heart; for patients whose cardiac muscle is already severely damaged, IABP support may not raise cardiac output sufficiently to meet the body's needs, creating the necessity for further circulatory support.
The working principle of ECMO is to draw a portion of the body's blood outside of the body, oxygenate it, and then return it to the circulation; this improves oxygen supply throughout the body, providing some compensation for the reduction in cardiac output caused by impaired heart function and improving blood flow to tissues and organs. Furthermore, the veno-arterial type of ECMO can reduce cardiac preload by diverting blood flow, reducing cardiac oxygen demand even more; therefore ECMO can be used to treat acute heart failure. ECMO can also be used to treat acute lung failure; for example, when ECMO is applied to treatment of patients with acute respiratory distress syndrome (ARDS), it can effectively increase blood oxygen content and ensure sufficient oxygen transport [4]. However, for the venous-femoral arterial modality, when ECMO flow is increased, there is a corresponding increase in left ventricular afterload, which, when severe, can restrict the opening of the aortic valve, affecting left ventricular ejection and possibly lead to thrombus formation in the left ventricle [5], [6]. In the venous-ascending aortic modality, on the other hand, continuous non-pulsating blood flow may reduce aortic root pressure during diastole, affecting blood supply to the cardiac muscle.
Due to the limitations of both methods, neither IABP nor ECMO alone can achieve ideal outcomes in patients with severe disease [7], while combining them can in principle have a synergistic and complementary effect. The goal of this article is to discuss the clinical experience of combining ECMO with IABP for the treatment of acute heart failure in adults.
Section snippets
Patients
In the period from January 2008 to July 2012, a total of 54 adult patients with acute heart failure received combined ECMO and IABP support at our hospital. Thirty-eight were male, 16 were female, and the mean age was 57 ± 11 (with a range of 24–75). The basic demographics of all patients are shown in Table 1. The surgical operations they received are shown in Table 2. In our study 39 patients received IABP first but could not maintain adequate circulation, and were then treated with ECMO; 15
Results
- 1.
Survival Rates and Prognosis
Thirty-four patients (63%) were successfully weaned from mechanical life support (weaned group); of these patients, 13 (24%) died from various complications after weaning, while 21 (39%) survived to discharge. Twenty patients (37%) were not weaned from mechanical circulatory support (un-weaned group); 14 of these patients (26%) died due to inability of the heart to recover its function, while six (11%) were taken off support when family members decided to forego
Discussion
There were 54 patients initially included in this study and all of them showed improvements in terms of overall circulation in addition to vasoactive drug applications; the rate of effectiveness was 100%. Thirty-four of the patients were successfully weaned from mechanical circulatory support, and 21 patients survived to discharge (39% of the total patient number). This shows that a combination of ECMO and IABP can be used to treat patients with serious symptoms after heart surgery and there is
Conflict of Interest
No conflicts of interest declared.
Acknowledgements
We specially thank Professor Ming Jia from the Capital Medical University affiliated Beijing Anzhen Hospital for his support.
References (16)
- et al.
Circulatory benefits of diastolic counterpulsation in an ischemic heart failure model after aortomyoplasty
J Thorac Cardiovasc Surg
(2002) - et al.
Extracorporeal membrane oxygenation for cardiac disease: no longer a mistaken diagnosis
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu
(2005) - et al.
Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support
Ann Thorac Surg
(2011) - et al.
A meta-analysis of complications and mortality of extracorporeal membrane oxygenation
Crit Care Resusc
(2013) - et al.
Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients
Heart Lung Circ
(2008) - et al.
Delayed institution of extracorporeal membrane oxygenation is associated with increased mortality rate and prolonged hospital stay
J Pediatr Surg
(2002) - et al.
Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults
Intensive Care Med
(2013) - et al.
ECMO cannulation controversies and complications
Semin Cardiothorac Vasc Anesth
(2009)
Cited by (0)
- 1
These authors contributed equally to this work.